You just read:

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue

News provided by

Johnson & Johnson

May 20, 2015, 07:30 ET